Methodological issues in AIDS clinical trials. Intent-to-treat analysis.
Tsiatis
A
A
Division of Biostatistics, Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts 02115.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D006801:Humans; D010349:Patient Compliance; D010352:Patient Dropouts; D016032:Randomized Controlled Trials as Topic / Q000379:methods